QUININE
Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)- its salts
QUININE은(는) 부속서 III에 등재되어 있으며 이 기록에 표시된 조건에서만 사용할 수 있습니다. 이 기록의 최대 농도: (a) 0.5% (as quinine base) (b) 0.2% (as quinine base).
기록 세부 정보
최대 농도
(a) 0.5% (as quinine base) (b) 0.2% (as quinine base)
INCI 용어집 명칭
QUININE
화학명
Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)- its salts
화학명 / IUPAC 명칭
(8S,9R)-6'-Methoxycinchonan-9-ol
규제 정보
식별된 원료
주요 데이터
화학적 정체 및 특성

Quinine
Quinine is a cinchona alkaloid that is cinchonidine in which the hydrogen at the 6-position of the quinoline ring is substituted by methoxy. It has a role as a non-narcotic analgesic, an antimalarial and a muscle relaxant. It is a conjugate base of a quinine(1+). It derives from a hydride of an (8S)-cinchonan. — ChEBI
- IUPAC 명칭
- (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
- 분자식
- C20H24N2O2
- 분자량
- 324.4 g/mol
- 정확한 질량
- 324.183778013 Da
- XLogP3
- 2.9
- 위상 극성 표면적
- 45.6 Ų
- 수소 결합 공여체
- 1
- 수소 결합 수용체
- 4
- 공유결합 단위
- 1
- 정의된 입체중심
- 4
다른 이름
보고된 명칭 16개 더 보기
외부 데이터베이스 식별자
추가 과학 데이터베이스의 근거
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Color/Form: Triboluminescent, orthorhombic needles from absolute alcohol 출처: Hazardous Substances Data Bank (HSDB)
- Color/Form: Bulky, white, amorphous powder or crystalline alkaloid 출처: Hazardous Substances Data Bank (HSDB)
- Color/Form: CRYSTALS TURN BROWN ON EXPOSURE TO AIR 출처: Hazardous Substances Data Bank (HSDB)
- Basic pKa: 8.56 출처: ChEMBL
- Basic pKa: 8.55 출처: ChEMBL
- Dissociation Constants: pK1 (18 °C) = 5.07; pK2 = 9.7 출처: Hazardous Substances Data Bank (HSDB)
- LogP: 3.44 출처: DrugBank
- LogP: log Kow = 3.44 출처: Hazardous Substances Data Bank (HSDB)
- LogP: 2.6 출처: Human Metabolome Database (HMDB)
- Melting Point: 57 °C 출처: DrugBank
- Melting Point: 177 °C (some decomposition) 출처: Hazardous Substances Data Bank (HSDB)
- Melting Point: Microcrystalline powder; mp: 57 °C; efflorescent; loses one water molecule in air, two water molecules over sulfuric acid; anhydrous at 125 °C /Quinine trihydrate/ 출처: Hazardous Substances Data Bank (HSDB)
- Melting Point: 57 °C 출처: Human Metabolome Database (HMDB)
- Odor: ODORLESS 출처: Hazardous Substances Data Bank (HSDB)
- Physical Description: Solid 출처: Human Metabolome Database (HMDB)
- Refractive Index: INDEX OF REFRACTION: 1.625 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: 500 mg/L (at 15 °C) 출처: DrugBank
- Solubility: In water, 500 mg/L at 15 °C 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: 1 g dissolves in: 1900 mL water, 760 mL boiling water 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: 1 g dissolves in: 80 mL benzene (18 mL at 50 °C), 1.2 mL chloroform, 250 mL dry ether, 20 mL glycerol, 0.8 mL alcohol, 1900 mL of 10% ammonia water; almost insoluble in petroleum ether 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: Soluble in ether, chloroform, carbon disulfide, glycerol, alkalies, and acids (with formation of salts) 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: Sol in pyrimidine 출처: Hazardous Substances Data Bank (HSDB)
- Solubility: 3.34e-01 g/L 출처: Human Metabolome Database (HMDB)
- pH: pH of saturated aqueous solution = 8.8 출처: Hazardous Substances Data Bank (HSDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). 출처: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Oral 출처: Toxin and Toxin Target Database (T3DB)
- Signal: Danger 출처: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (22.9%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (28.4%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (99.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (28.4%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H334 (83.1%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory] 출처: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P233, P260, P261, P264, P264+P265, P270, P271, P272, P280, P284, P301+P317, P302+P352, P304+P340, P305+P351+P338, P321, P330, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 201 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
- Signal: Warning 출처: Hazardous Chemical Information System (HCIS), Safe Work Australia
- GHS Hazard Statements: H302: Harmful if swallowed [Warning Acute toxicity, oral]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin] 출처: Hazardous Chemical Information System (HCIS), Safe Work Australia
- Precautionary Statement Codes: P261, P264, P270, P272, P280, P301+P317, P302+P352, P321, P330, P333+P317, P362+P364, and P501 (click each P-code to see the statement) 출처: Hazardous Chemical Information System (HCIS), Safe Work Australia
- Signal: Danger 출처: Hazardous Substances Data Bank (HSDB)
- GHS Hazard Statements: H315: Causes skin irritation [Warning Skin corrosion/irritation]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory] 출처: Hazardous Substances Data Bank (HSDB)
- Precautionary Statement Codes: P233, P260, P261, P264, P264+P265, P271, P272, P280, P284, P302+P352, P304+P340, P305+P351+P338, P321, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement) 출처: Hazardous Substances Data Bank (HSDB)
- Health Effects: It is usual for quinine in therapeutic doses to cause cinchonism; in rare cases, it may even cause death (usually by pulmonary edema). Quinine can worsen hemoglobinuria, myasthenia gravis and optic neuritis. It can cause paralysis if accidentally injected into a nerve, and is extremely toxic in overdose[Wikipedia] 출처: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: IDENTIFICATION AND USE: Quinine is a bulky, white, amorphous powder or crystalline alkaloid, used as medication: non-narcotic analgesics; antimalarial; central muscle relaxants. It is also used as flavor in carbonated beverages. HUMAN EXPOSURE AND TOXICITY: Serious hypersensitivity reactions, including anaphylactic shock, anaphylactoid reactions, urticaria, serious skin rashes, angioedema, facial edema, bronchospasm, and pruritus, have been reported with quinine. In addition, thrombocytopenia, hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP), immune thrombocytopenic purpura, blackwater fever, disseminated intravascular coagulation, leukopenia, neutropenia, granulomatous hepatitis, and acute interstitial nephritis have been reported and may also be due to hypersensitivity reactions to the drug. Potentially fatal cardiac arrhythmias, including torsades de pointes and ventricular fibrillation, have been reported rarely during quinine therapy. At least 1 case of fatal ventricular arrhythmia has been reported in a geriatric patient with preexisting prolonged QT interval treated with IV quinine sulfate for Plasmodium falciparum malaria. Visual impairment can range 출처: Hazardous Substances Data Bank (HSDB)
- Toxicity Summary: The theorized mechanism of action for quinine and related anti-malarial drugs is that these drugs are toxic to the malaria parasite. Specifically, the drugs interfere with the parasite's ability to break down and digest hemoglobin. Consequently, the parasite starves and/or builds up toxic levels of partially degraded hemoglobin in itself. 출처: Toxin and Toxin Target Database (T3DB)
- Uses: Medicine (antimalarial) as the alkaloid or as numerous salts and derivatives; flavoring in carbonated beverages 출처: Hazardous Substances Data Bank (HSDB)
- Uses: Flavor in carbonated beverages. 출처: Hazardous Substances Data Bank (HSDB)
- Uses: MEDICATION 출처: Hazardous Substances Data Bank (HSDB)
- Uses: MEDICATION (VET) 출처: Hazardous Substances Data Bank (HSDB)
- Uses: For more Uses (Complete) data for QUININE (8 total), please visit the HSDB record page. 출처: Hazardous Substances Data Bank (HSDB)
- Uses: Use (kg; approx.) in Germany (2009): >5000; Use (kg) in USA (2002): 56800; Consumption (g per capita; approx.) in Germany (2009): 0.0611; Consumption (g per capita) in the USA (2002): 0.201; Calculated removal (%): 41.8 출처: NORMAN Suspect List Exchange
- Uses: For the treatment of malaria and leg cramps. Used as an antipyretic (fever-reducing), antimalarial, analgesic (painkilling), and anti-inflammatory. It is also used as a flavor component of tonic water and bitter lemon. 출처: Toxin and Toxin Target Database (T3DB)
매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기
과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.
추가 출처 적용 범위 및 일치 상태
| 출처 | 결과 | 확인됨 |
|---|---|---|
| NIH PubChem PUG-View | 정확히 일치 | 2026-08-31 |
기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.
체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.
QUININE의 목록 링크
QUININE의 관련 기록
이 기록에 직접 일치하는 항목이 제한적이어서, 부속서 III의 인접 항목도 함께 표시합니다.
Sodium monofluorophosphate
QUININE에 대한 부속서 III의 의미
QUININE은(는) EU 화장품 규정 1223/2009 부속서 III에 따른 사용제한 물질입니다. 화장품에서의 사용은 위 항목에 명시된 농도 한도, 제품 유형 제한 및 필수 경고 문구를 포함한 특정 조건에서만 허용됩니다.
이 물질을 처방에 포함할 때는 최대 농도, 제품 범위 및 경고 표시 등 모든 조건을 동시에 충족해야 합니다. 한 조건을 준수한다고 해서 다른 조건이 면제되지 않습니다.
이 기록은 명칭 및 식별자 교차 참조를 위해 CosIng 목록 원료 1건과 연결되어 있습니다. 또한 이 페이지에는 식별자, 부속서 논리 또는 명칭 패턴이 겹치는 관련 부속서 기록 12건이 표시됩니다.
규제 준수 체크리스트
- 처방 농도가 다음을 초과하지 않는지 확인하세요: (a) 0.5% (as quinine base) (b) 0.2% (as quinine base)
- 제품 유형 적합성을 확인하세요: (a) Hair rinse-off products (b) Hair leave-on products
- 사용 조건을 제품정보파일(PIF)에 기록하세요.